1-20 of 33
Authors: Ph. Gabriel Steg
Save search
Sort by
Journal Article

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

PDF
C Michael Gibson and others
European Heart Journal, Volume 45, Issue 47, 14 December 2024, Pages 5023–5038, https://doi.org/10.1093/eurheartj/ehae614
Published: 02 September 2024
Journal Article

Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial

PDF
Neila Sayah and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1173–1176, https://doi.org/10.1093/eurheartj/ehad889
Published: 22 January 2024
Journal Article

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial

PDF
Gregory G Schwartz and others
European Heart Journal, Volume 44, Issue 16, 21 April 2023, Pages 1408–1417, https://doi.org/10.1093/eurheartj/ehad144
Published: 05 March 2023
Journal Article

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

PDF
Steven H J Hageman and others
European Heart Journal, Volume 43, Issue 18, 7 May 2022, Pages 1715–1727, https://doi.org/10.1093/eurheartj/ehac056
Published: 15 February 2022
Journal Article

The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl

PDF
Ph Gabriel Steg and Deepak L Bhatt
European Heart Journal, Volume 42, Issue 47, 14 December 2021, Pages 4865–4866, https://doi.org/10.1093/eurheartj/ehab760
Published: 03 November 2021
Journal Article

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial

PDF
Michael Szarek and others
European Heart Journal, Volume 41, Issue 44, 21 November 2020, Pages 4245–4255, https://doi.org/10.1093/eurheartj/ehaa649
Published: 14 October 2020
Journal Article

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

PDF
Peter R Sinnaeve and others
European Heart Journal, Volume 41, Issue 24, 21 June 2020, Pages 2248–2258, https://doi.org/10.1093/eurheartj/ehz809
Published: 16 November 2019
Journal Article

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

PDF
Harvey D White and others
European Heart Journal, Volume 40, Issue 33, 1 September 2019, Pages 2801–2809, https://doi.org/10.1093/eurheartj/ehz299
Published: 23 May 2019
Journal Article

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

PDF
Harsh B Golwala and others
European Heart Journal, Volume 39, Issue 19, 14 May 2018, Pages 1726–1735a, https://doi.org/10.1093/eurheartj/ehy162
Published: 13 April 2018
Journal Article

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

PDF
Brian A Bergmark and others
European Heart Journal, Volume 39, Issue 24, 21 June 2018, Pages 2255–2262, https://doi.org/10.1093/eurheartj/ehx809
Published: 31 January 2018
Journal Article
EDITOR'S CHOICE

Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC/AHA very high risk criteria Get access

PDF
M Johanneke van den Berg and others
European Heart Journal, Volume 38, Issue 43, 14 November 2017, Pages 3211–3218, https://doi.org/10.1093/eurheartj/ehx102
Published: 28 March 2017
Journal Article
EDITOR'S CHOICE FAST TRACK

The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX

PDF
J. Antonio Gutierrez and others
European Heart Journal, Volume 37, Issue 14, 7 April 2016, Pages 1122–1130, https://doi.org/10.1093/eurheartj/ehv498
Published: 23 September 2015
Journal Article

Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis Get access

PDF
Boris Hansel and others
European Heart Journal, Volume 36, Issue 40, 21 October 2015, Pages 2716–2728, https://doi.org/10.1093/eurheartj/ehv347
Published: 04 August 2015
Journal Article

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes Get access

PDF
Christoph Varenhorst and others
European Heart Journal, Volume 36, Issue 29, 1 August 2015, Pages 1901–1912, https://doi.org/10.1093/eurheartj/ehv116
Published: 02 May 2015
Journal Article
EDITOR'S CHOICE

High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events Get access

PDF
Sheldon M. Singh and others
European Heart Journal, Volume 36, Issue 16, 21 April 2015, Pages 976–983, https://doi.org/10.1093/eurheartj/ehu357
Published: 09 September 2014
Journal Article
EDITOR'S CHOICE FAST TRACK

Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial Get access

PDF
William Wijns and others
European Heart Journal, Volume 35, Issue 40, 21 October 2014, Pages 2812–2820, https://doi.org/10.1093/eurheartj/ehu318
Published: 08 August 2014
Journal Article

The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

PDF
Steen Husted and others
European Heart Journal, Volume 35, Issue 23, 14 June 2014, Pages 1541–1550, https://doi.org/10.1093/eurheartj/ehu075
Published: 28 March 2014
Journal Article
EDITOR'S CHOICE

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type Get access

PDF
Edoardo Camenzind and others
European Heart Journal, Volume 35, Issue 29, 1 August 2014, Pages 1932–1948, https://doi.org/10.1093/eurheartj/ehu084
Published: 13 March 2014
Journal Article

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry Get access

PDF
Dharam J. Kumbhani and others
European Heart Journal, Volume 35, Issue 41, 1 November 2014, Pages 2864–2872, https://doi.org/10.1093/eurheartj/ehu080
Published: 28 February 2014
Journal Article
EDITOR'S CHOICE GUIDELINES

2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology

PDF
Task Force Members and others
European Heart Journal, Volume 34, Issue 38, 7 October 2013, Pages 2949–3003, https://doi.org/10.1093/eurheartj/eht296
Published: 30 August 2013